Jose Leal presented HepatoPredict at the ESSO 40, in the session Future Oncology, where he had the opportunity to discuss HepatoPredict and its validation roadmap with experts from different institutions.

Jose Leal presented HepatoPredict at the ESSO 40, in the session Future Oncology, where he had the opportunity to discuss HepatoPredict and its validation roadmap with experts from different institutions.

Related Posts

October marked Liver Cancer Awareness Month, a time to spotlight one of the world’s fastest-growing and deadliest cancers: Over 900,000

Ophiomics is heading to Riyadh! We will be attending and exhibiting at the Global Health Exhibition, taking place 27–30 October.

Precision in IVD Tools: How Machine Learning Elevates HepatoDetect for Early HCC Detection Early detection of hepatocellular carcinoma (HCC) in

The most innovative diagnostic test is of little value if it cannot be implemented efficiently in real-world clinical settings. Current